Follow
Valentina Tabanelli
Valentina Tabanelli
Divisione di Diagnosi Emolinfopatologica, Istituto Europeo di Oncologia
Verified email at ieo.it
Title
Cited by
Cited by
Year
CD30 expression in peripheral T-cell lymphomas
E Sabattini, M Pizzi, V Tabanelli, P Baldin, CS Sacchetti, C Agostinelli, ...
Haematologica 98 (8), e81-e82, 2013
1612013
Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue
S Ciavarella, MC Vegliante, M Fabbri, S De Summa, F Melle, G Motta, ...
Annals of Oncology 29 (12), 2363-2370, 2018
1142018
Blastic plasmacytoid dendritic cell neoplasm: state of the art and prospects
MR Sapienza, A Pileri, E Derenzini, F Melle, G Motta, S Fiori, A Calleri, ...
Cancers 11 (5), 595, 2019
992019
Randomized trial comparing R-CHOP versus high-dose sequential chemotherapy in high-risk patients with diffuse large B-cell lymphomas
S Cortelazzo, C Tarella, AM Gianni, M Ladetto, AM Barbui, A Rossi, ...
Journal of Clinical Oncology 34 (33), 4015-4022, 2016
862016
Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target
MR Sapienza, F Abate, F Melle, S Orecchioni, F Fuligni, M Etebari, ...
haematologica 104 (4), 729, 2019
742019
Histiocytic and dendritic cell neoplasms: what have we learnt by studying 67 cases
F Facchetti, SA Pileri, L Lorenzi, V Tabanelli, L Rimsza, S Pittaluga, ...
Virchows Archiv 471, 467-489, 2017
692017
Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified
MA Laginestra, L Cascione, G Motta, F Fuligni, C Agostinelli, M Rossi, ...
Modern Pathology 33 (2), 179-187, 2020
452020
CD38, BCL-2, PD-1, and PD-1L expression in nodal peripheral T-cell lymphoma: Possible biomarkers for novel targeted therapies?
F Zaja, V Tabanelli, C Agostinelli, A Calleri, A Chiappella, M Varettoni, ...
American journal of hematology 92 (1), E1-E2, 2017
452017
Molecular genetics of peripheral T-cell lymphomas
PP Piccaluga, V Tabanelli, SA Pileri
International journal of hematology 99, 219-226, 2014
412014
Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specified
MA Laginestra, PP Piccaluga, F Fuligni, M Rossi, C Agostinelli, S Righi, ...
Blood Cancer Journal 4 (11), e259-e259, 2014
352014
Recurrent PDL1 expression and PDL1 (CD274) copy number alterations in breast implant–associated anaplastic large cell lymphomas
V Tabanelli, C Corsini, S Fiori, C Agostinelli, A Calleri, S Orecchioni, ...
Human Pathology 90, 60-69, 2019
332019
Distinctive histogenesis and immunological microenvironment based on transcriptional profiles of follicular dendritic cell sarcomas
MA Laginestra, C Tripodo, C Agostinelli, G Motta, S Hartmann, C Döring, ...
Molecular cancer research 15 (5), 541-552, 2017
302017
Gene expression signatures for the accurate diagnosis of peripheral T-cell lymphoma entities in the routine clinical practice
C Amador, A Bouska, G Wright, DD Weisenburger, AL Feldman, ...
Journal of clinical oncology 40 (36), 4261, 2022
262022
Systemic Epstein-Barr-virus-positive T cell lymphoproliferative childhood disease in a 22-year-old Caucasian man: a case report and review of the literature
V Tabanelli, C Agostinelli, E Sabattini, A Gazzola, F Bacci, S Capria, ...
Journal of Medical Case Reports 5, 1-5, 2011
192011
Complete and long‐lasting cytologic and molecular remission of FIP1L1‐PDGFRA‐positive acute eosinophil myeloid leukaemia, treated with low‐dose imatinib …
D Barraco, F Carobolante, A Candoni, E Simeone, P Piccaluga, ...
European Journal of Haematology 92 (6), 541-545, 2014
172014
Dual targeting of the DNA damage response pathway and BCL-2 in diffuse large B-cell lymphoma
A Rossi, S Orecchioni, P Falvo, V Tabanelli, E Baiardi, C Agostinelli, ...
Leukemia 36 (1), 197-209, 2022
142022
Peripheral T-cell lymphoma, not otherwise specified: clinical manifestations, diagnosis, and future treatment
SA Pileri, V Tabanelli, S Fiori, A Calleri, F Melle, G Motta, D Lorenzini, ...
Cancers 13 (18), 4535, 2021
122021
A three-gene signature based on MYC, BCL-2 and NFKBIA improves risk stratification in diffuse large B-cell lymphoma
E Derenzini, S Mazzara, F Melle, G Motta, M Fabbri, R Bruna, ...
Haematologica 106 (9), 2405, 2021
122021
Definition and validation of the new elderly prognostic index (EPI) for elderly patients with diffuse large B-cell lymphoma integrating geriatric and clinical assessment …
M Spina, F Merli, B Puccini, F Cavallo, MG Cabras, A Fabbri, F Angrilli, ...
Blood 134, 398, 2019
122019
Predictive and prognostic molecular factors in diffuse large B-cell lymphomas
SA Pileri, C Tripodo, F Melle, G Motta, V Tabanelli, S Fiori, MC Vegliante, ...
Cells 10 (3), 675, 2021
112021
The system can't perform the operation now. Try again later.
Articles 1–20